Clinical trial
Safety & Efficacy of Genakumab in Patients With Frequent Flares
NCT05983445 is registered in ClinicalTrials.gov with Changchun GeneScience Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety & Efficacy of Genakumab in Patients With Frequent Flares
- Lead sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 11, 2023
- Completion date
- April 3, 2024
- Enrollment
- 313 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute gout arthritis